Epkinly (epcoritamab-bysp) — Medica
Human immunodeficiency virus (HIV)-related B-cell lymphomas (including HIV-related DLBCL, primary effusion lymphoma, and HHV8-positive DLBCL)
Initial criteria
- age ≥ 18 years
- has received two or more lines of systemic therapy
- medication is given as a single agent
- medication is prescribed by or in consultation with an oncologist
Approval duration
1 year